Origin Therapeutics Holdings (XCNQ:ORIG) Net Income From Continuing Operations : C$-2.90 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Origin Therapeutics Holdings's net income from continuing operations for the three months ended in Jun. 2023 was C$-0.06 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2023 was C$-2.90 Mil.

Origin Therapeutics Holdings Net Income From Continuing Operations Historical Data

The historical data trend for Origin Therapeutics Holdings's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Net Income From Continuing Operations Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Net Income From Continuing Operations

-1.45

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Net Income From Continuing Operations	Get a 7-Day Free Trial				-0.33	-0.55	-0.13	-2.15	-0.06

Origin Therapeutics Holdings Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.90 Mil.